Abstract | OBJECTIVES: METHODS: Two models of chronic inflammatory pain in BALB/c mice paw were used: infection with L. amazonensis and CFA stimulation. Both animals models received daily treatment with Glucantime (10 mg/kg, i.p.) and during the treatment was measured the mechanical hyperalgesia with electronic version of von Frey filaments. After the treatment, the paw skin sample was collected for analysis of myeloperoxidase (MPO) and N-acetyl-β- glucosaminidase (NAG) activity, and IL-1β, TNF-α, IL-6, IFN-γ and IL-10 cytokines production by ELISA. KEY FINDINGS: CONCLUSIONS: Our data demonstrated that Glucantime reduced the chronic inflammatory pain induced by L. amazonensis and CFA stimuli by inhibiting the hyperalgesic cytokines production.
|
Authors | Suelen S da Silva, Sandra S Mizokami, Jacqueline R Fanti, Idessania N Costa, Juliano Bordignon, Ionice Felipe, Wander R Pavanelli, Waldiceu A Verri Jr, Ivete Conchon Costa |
Journal | The Journal of pharmacy and pharmacology
(J Pharm Pharmacol)
Vol. 70
Issue 6
Pg. 768-777
(Jun 2018)
ISSN: 2042-7158 [Electronic] England |
PMID | 29532470
(Publication Type: Journal Article)
|
Copyright | © 2018 Royal Pharmaceutical Society. |
Chemical References |
- Cytokines
- Organometallic Compounds
- Meglumine
- Meglumine Antimoniate
- Freund's Adjuvant
- Peroxidase
- Acetylglucosaminidase
|
Topics |
- Acetylglucosaminidase
(metabolism)
- Animals
- Chronic Pain
(complications, drug therapy)
- Cytokines
(metabolism)
- Freund's Adjuvant
- Inflammation
(chemically induced, complications, drug therapy)
- Leishmaniasis, Cutaneous
(drug therapy)
- Male
- Meglumine
(therapeutic use)
- Meglumine Antimoniate
- Mice
- Organometallic Compounds
(therapeutic use)
- Peroxidase
(metabolism)
- Skin
(metabolism)
|